Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone Nasal Spray for Gambling Disorder
NCT03223896Phase 2Completed
- Sponsor
- Finnish Institute for Health and Welfare
- Start
- Feb 2017
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naloxone in gambling disorder (GD), sponsored by Finnish Institute for Health and Welfare. Started Feb 2017; status: completed.
02
Drugs
naloxone
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT03223896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03223896.